Evidence map›Paper›PMID 36295033›Full record

ReviewLife (Basel, Switzerland)2022

Increased Scabies Incidence at the Beginning of the 21st Century: What Do Reports from Europe and the World Show?

Marija Delaš Aždajić, Iva Bešlić, Ana Gašić, Nikola Ferara, Lovre Pedić, Liborija Lugović-Mihić

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Rising scabies incidence in Spain: a retrospective observational analysis of four national data sources, 2011 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marija Delaš AždajićDepartment of Dermatovenereology, University Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0003-3619-0216
Iva BešlićDepartment of Dermatovenereology, University Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia.
Ana GašićDepartment of Dermatovenereology, University Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia.
Nikola FeraraDepartment of Dermatovenereology, University Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0002-3647-3390
Lovre PedićDepartment of Dermatovenereology, University Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia.
Liborija Lugović-MihićDepartment of Dermatovenereology, University Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0001-7494-5742

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reports from various countries have described increasing numbers of scabies cases, especially in the past two decades. The epidemiological data for various world regions showed prevalence estimates ranging from 0.2% to 71%, with the highest prevalence in the Pacific region and Latin America. Therefore, geographically, scabies occurs more commonly in the developing world, tropical climates, and in areas with a lack of access to water. According to results from specific regions of the world, the greatest burdens from scabies were recorded for East Asia, Southeast Asia, Oceania, tropical Latin America, and South Asia. Among countries with the highest rates, the top 10 were Indonesia, China, Timor-Leste, Vanuatu, Fiji, Cambodia, Laos, Myanmar, Vietnam, and the Seychelles. From Europe, available data shows an increasing trend in scabies infestation, particularly evident among populations with associated contributing factors, such as those who travel frequently, refugees, asylum seekers, those who regularly lack drinking water and appropriate hygiene and are of a younger age, etc. This increase in observed cases in the last 10-20 years has been evidenced by research conducted in Germany, France, Norway, and Croatia, among other countries. In addition, increased scabies transmission was also recorded during the COVID-19 pandemic and may have been the result of increased sexual intercourse during that time. Despite all the available treatment options, scabies commonly goes unrecognized and is therefore not treated accordingly. This trend calls for a prompt and synergistic reaction from all healthcare professionals, governmental institutions, and non-governmental organizations, especially in settings where population migration is common and where living standards are low. Furthermore, the proper education of whole populations and accessible healthcare are cornerstones of outbreak prevention. Accurate national data and proper disease reporting should be a goal for every country worldwide when developing strategic plans for preventing and controlling the community spread of scabies.

Indexed as

diagnosticsepidemiologyepidemiology trendsreportsrisk factorsscabies

Identifiers

PMID36295033
PMCPMC9604680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.